179 related articles for article (PubMed ID: 22453538)
41. Antagonism of long-acting beta2-adrenoceptor agonism.
Lipworth BJ
Br J Clin Pharmacol; 2002 Sep; 54(3):231-45. PubMed ID: 12236842
[TBL] [Abstract][Full Text] [Related]
42. Beta agonist use during asthma exacerbations: how much is too much?
Patel M; Perrin K; Beasley R
N Z Med J; 2011 Apr; 124(1332):77-80. PubMed ID: 21747427
[TBL] [Abstract][Full Text] [Related]
43. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial.
Bodzenta-Lukaszyk A; van Noord J; Schröder-Babo W; McAulay K; McIver T
Curr Med Res Opin; 2013 May; 29(5):579-88. PubMed ID: 23368897
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β
Ferguson GT; Darken P; Ballal S; Siddiqui MK; Singh B; Attri S; Holmgren U; de Nigris E
Adv Ther; 2020 Jun; 37(6):2956-2975. PubMed ID: 32335859
[TBL] [Abstract][Full Text] [Related]
46. Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD.
Cazzola M; Santus P; Di Marco F; Boveri B; Castagna F; Carlucci P; Matera MG; Centanni S
Respir Med; 2003 May; 97(5):453-7. PubMed ID: 12735659
[TBL] [Abstract][Full Text] [Related]
47. Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review.
Solidoro P; Patrucco F; Bagnasco D
Expert Rev Respir Med; 2019 Nov; 13(11):1087-1094. PubMed ID: 31498714
[No Abstract] [Full Text] [Related]
48. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2011 Dec; (12):CD004106. PubMed ID: 22161385
[TBL] [Abstract][Full Text] [Related]
49. Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
Yi F; Zhan C; Liu B; Li H; Zhou J; Tang J; Peng W; Luo W; Chen Q; Lai K
Respir Res; 2022 Oct; 23(1):279. PubMed ID: 36217131
[TBL] [Abstract][Full Text] [Related]
50. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
[TBL] [Abstract][Full Text] [Related]
51. An innovative corticosteroid/long-acting β
Usmani O; Roche N; Marshall J; Danagher H; Price D
Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
[No Abstract] [Full Text] [Related]
52. Adjustable and fixed dosing with budesonide/ formoterol via a single inhaler in asthma patients: the ASSURE study.
Ind PW; Haughney J; Price D; Rosen JP; Kennelly J
Respir Med; 2004 May; 98(5):464-75. PubMed ID: 15139576
[TBL] [Abstract][Full Text] [Related]
53. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
Welsh EJ; Cates CJ; Poole P
Cochrane Database Syst Rev; 2013 May; (5):CD007891. PubMed ID: 23728670
[TBL] [Abstract][Full Text] [Related]
54. Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma.
Price D; Hillyer EV
Expert Rev Respir Med; 2014 Jun; 8(3):275-91. PubMed ID: 24802285
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the effects of budesonide/formoterol maintenance and reliever therapy with fluticasone/salmeterol fixed-dose treatment on airway inflammation and small airway impairment in patients who need to step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Hozawa M
Pulm Pharmacol Ther; 2014 Apr; 27(2):190-6. PubMed ID: 24388868
[TBL] [Abstract][Full Text] [Related]
56. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
Lyseng-Williamson KA; Plosker GL
Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
[TBL] [Abstract][Full Text] [Related]
57. Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma.
Beasley R; Holliday M; Reddel HK; Braithwaite I; Ebmeier S; Hancox RJ; Harrison T; Houghton C; Oldfield K; Papi A; Pavord ID; Williams M; Weatherall M;
N Engl J Med; 2019 May; 380(21):2020-2030. PubMed ID: 31112386
[TBL] [Abstract][Full Text] [Related]
58. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
59. Use of long-acting beta-agonists and inhaled steroids in asthma: meta-analysis of observational studies.
Hirst C; Calingaert B; Stanford R; Castellsague J
J Asthma; 2010 May; 47(4):439-46. PubMed ID: 20528600
[TBL] [Abstract][Full Text] [Related]
60. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol.
Blais L; Beauchesne MF; Forget A
Respir Med; 2009 Feb; 103(2):237-43. PubMed ID: 18930647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
